Evans John M.'s Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Feb 2, 2026
- Accession no.
- 0001193125-26-033600
- Filed
- Feb 2, 2026
- Trade date
- Jan 29-31, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.44M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Evans John M.CIK 0001786304 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2026 | Common Stock | MOption exerciseAcquired | +19,336 | $0.67 | +$12,955.12 | 1,006,003 | Direct | |
| Jan 29, 2026 | Common Stock | MOption exerciseAcquired | +5,664 | $0.67 | +$3,794.88 | 1,011,667 | Direct | |
| Jan 29, 2026 | Common Stock | SSaleDisposed | −16,333 | $29.19 | −$476,760.27 | 995,334 | Direct | |
| Jan 29, 2026 | Common Stock | SSaleDisposed | −8,667 | $29.74 | −$257,756.58 | 986,667 | Direct | |
| Jan 30, 2026 | Common Stock | MOption exerciseAcquired | +25,000 | $0.67 | +$16,750 | 1,011,667 | Direct | |
| Jan 30, 2026 | Common Stock | SSaleDisposed | −22,094 | $28.27 | −$624,597.38 | 989,573 | Direct | |
| Jan 30, 2026 | Common Stock | SSaleDisposed | −2,906 | $29.00 | −$84,274 | 986,667 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2026 | Common Stock | MOption exerciseDisposed | −19,336 | $0.00 | $0 | 0 | Direct | |
| Jan 29, 2026 | Common Stock | MOption exerciseDisposed | −5,664 | $0.00 | $0 | 93,672 | Direct | |
| Jan 30, 2026 | Common Stock | MOption exerciseDisposed | −25,000 | $0.00 | $0 | 68,672 | Direct | |
| Jan 31, 2026 | Common Stock | AGrant or awardAcquired | +180,000 | $0.00 | $0 | 180,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.